ABC | Volume 112, Nº6, Junho 2019

Correlação Anatomoclínica Issa e Benvenuti Infiltrado pulmonar e obliteração da ponta do ventrículo esquerdo em homem jovem Arq Bras Cardiol. 2019; 112(6):793-802 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons Figura 12 – Constituição histológica do endocárdio acometido, compatível com endomiocardiofibrose. Há trombose luminal (seta), área superficial de fibrose densa (asterisco) e área subjacente de fibrose frouxa com vasos neoformados e focos de discreto infiltrado inflamatório (duplo asterisco). Hematoxilina-eosina, X 25 1. Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9-I16. 2. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033-69, 3069a-3069k. 3. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339(6):364-9. 4. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54(3):220-8. 5. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J AmColl Cardiol. 1995;26(7):1699-708. 6. Arad M, Penas-Lado M, Monserrat L, Maron BJ, Sherrid M, Ho CY, et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005;112(18):2805-11. 7. Beaton A, Mocumbi AO. Diagnosis and management of endomyocardial fibrosis. Cardiol Clin. 2017;35(1):87-98. 8. Nunes MC, Guimarães Jr MH, Diamantino AC, Gelape CL, Ferrari TC. Cardiac Manifestations of parasitic diseases. Heart. 2017;103(9):651-8. 9. Alter P, Maisch B. Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. Int J Cardiol. 2006;108(1):112-3. 10. Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture’s disease (anti-GBM). J Autoimmun. 2014 Feb-Mar;48-49:108-12. 11. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387 (10021):882-93. 12. Siciliano RF, Mansur AJ, Castelli JB, Arias V, Grinberg M, Levison ME, et al. Community-acquired culture-negative endocarditis: clinical characteristics and risk factors for mortality. Int J Infect Dis. 2014 Aug;25:191-5. 13. Issa VS, Dinardi LF, Pereira TV, Almeida LK, Barbosa TS, Benvenutti LA, et al. Diagnostic discrepancies in clinical practice: An autopsy study in patients with heart failure. Medicine (Baltimore). 2017;96(4):e5978. 14. Jobs A, Simon R, Waha S, Rogacev K, Katalinic A, Babaev V, et al. Pneumonia and Inflammation in acute decompensated heart failure: a registry-based analysis of 1939 patients. Eur Heart J Acute Cardiovasc Care. 2018;7(4):362-70 15. Elliott P, McKenna W. Hypertrophic cardiomyopathy. Lancet. 2004;363(9424):1881-91. 16. Iglezias SD, Benvenuti LA, Calabrese F, Salemi VM, Silva AM, Carturan E, et al. Endomyocardial fibrosis: pathological andmolecular findings of surgically resectedventricularendomyocardium.VirchowsArch.2008;453(3):233-41. 17. Salemi VM, Iglezias SD, Benvenuti LA, Filho JC, Rochitte CE, Shiozaki AA, et al. An unusual association of endomyocardial fibrosis and hypertrophic cardiomyopathy in a patient with heart failure. Cardiovasc Pathol. 2012;21(2):e23-5. 18. Thiene G, Basso C, Calabrese F, Angelini A, Valente M. Twenty years of progresss and beckoning frontiers in cardiovascular pathology: cardiomyopathies. Cardiovasc Pathol. 2005;14(4):165-9. 19. Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, et al. TheMOGE (S) classification for a phenotype-genotype nomenclature of cardiomyopathy. J Am Coll Cardiol. 2013;62(22):2046-72. Referências 802